(Q38708094)

5 September 2017

Dydrogesterone use in early pregnancy (English)

1 reference

5 September 2017

1 reference

Fadi Ghazi Mirza

1

1 reference

PubMed ID

26800266

5 September 2017

Ameet Patki

series ordinal

2

1 reference

PubMed ID

26800266

5 September 2017

Claire Pexman-Fieth

series ordinal

3

1 reference

5 September 2017

22 January 2016

1 reference

Gynecological Endocrinology

5 September 2017

1 reference

5 September 2017

32

1 reference

5 September 2017

2

1 reference

5 September 2017

97-106

1 reference

First trimester endocrinology: consequences for diagnosis and treatment of pregnancy failure

5 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Progesterone as an immunomodulatory molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Unexplained infertility: evaluation of the luteal phase; results of the National Center for Infertility Research at Michigan

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Clinical pharmacology of RU 486--an antiprogestin and antiglucocorticoid

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Oral micronized progesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Progesterone and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Oral dydrogesterone versus intravaginal micronised progesterone as luteal phase support in assisted reproductive technology (ART) cycles: results of a randomised study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Selectivity and potency of the retroprogesterone dydrogesterone in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Endocrine disruptors, genital development, and hypospadias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Vaginal bleeding in the first 20 weeks of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Incidence and outcome of bleeding before the 20th week of pregnancy: prospective study from general practice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Treatment options for threatened miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Threatened abortion: a risk factor for poor pregnancy outcome, a population-based screening study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Early risk factors for miscarriage: a prospective cohort study in pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Dydrogesterone in threatened miscarriage: a Malaysian experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Dydrogesterone in threatened abortion: pregnancy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Dydrogesterone support in threatened miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

A systematic review of dydrogesterone for the treatment of threatened miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Recurrent miscarriage: causes, evaluation and management

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Dydrogesterone in the reduction of recurrent spontaneous abortion

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

A systematic review of dydrogesterone for the treatment of recurrent miscarriage

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Role of uterine artery Doppler velocimetry indices and plasma adrenomedullin level in women with unexplained recurrent pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

A Randomized Trial of Progesterone in Women with Recurrent Miscarriages.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Spontaneous abortion and recurrent miscarriage: A comparison of cytogenetic diagnosis in 250 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

New media and how to make a quantum leap

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Dehydrogesterone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Modulating fertility outcome in assisted reproductive technologies by the use of dydrogesterone

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Comparison of oral dydrogestrone with progesterone gel and micronized progesterone for luteal support in 1,373 women undergoing in vitro fertilization: a randomized clinical study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Oral dydrogesterone versus vaginal progesterone gel in the luteal phase support: randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Dydrogesterone treatment for menstrual-cycle regularization in routine clinical practice: a multicenter observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Dydrogesterone use during pregnancy: overview of birth defects reported since 1977

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

Preimplantation hormonal differences between the conception and non- conception menstrual cycles of 32 normal women

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F09513590.2015.1121982

10.3109/09513590.2015.1121982

21 January 2018

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26800266